All News about AVEO Pharmaceuticals, Inc. - Common Stock
![](https://ml.globenewswire.com/media/2e9934c8-5039-41b0-8b9a-b6d083256851/small/aveo-lg-chem-logohi-resolution-jpg.jpg)
![](https://ml.globenewswire.com/media/2e9934c8-5039-41b0-8b9a-b6d083256851/small/aveo-lg-chem-logohi-resolution-jpg.jpg)
![](https://ml.globenewswire.com/media/2e9934c8-5039-41b0-8b9a-b6d083256851/small/aveo-lg-chem-logohi-resolution-jpg.jpg)
![](https://www.investors.com/wp-content/uploads/2018/04/stock-drugs-12-adobe.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/10/18/aapharma_0.png?width=1200&height=800&fit=crop)
LG Chem Scoops AVEO Oncology At 43% Premium
October 18, 2022
Via Benzinga
![](https://ml.globenewswire.com/media/2e9934c8-5039-41b0-8b9a-b6d083256851/small/aveo-lg-chem-logohi-resolution-jpg.jpg)
Via GlobeNewswire
![](https://ml.globenewswire.com/media/2e9934c8-5039-41b0-8b9a-b6d083256851/small/aveo-lg-chem-logohi-resolution-jpg.jpg)
![](https://www.globenewswire.com/Content/Images/intrado.png)
AVEO Oncology Stockholders Approve Acquisition by LG Chem
January 05, 2023
Via GlobeNewswire
![](https://www.marketbeat.com/logos/articles/small_stock-image_20038039_S.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/analyst_ratings_image_7118.png?width=1200&height=800&fit=crop)
Benzinga's Top Ratings Upgrades, Downgrades For November 8, 2022
November 08, 2022
Via Benzinga
![](https://ml.globenewswire.com/media/aeea7200-7231-49dd-b4ba-ec680464b28c/small/brodsky-smith-logo-png-png.png)
From Brodsky & Smith LLC
Via GlobeNewswire
![](https://cdn.benzinga.com/files/images/story/2022/analyst_ratings_image_6213.png?width=1200&height=800&fit=crop)
Benzinga's Top Ratings Upgrades, Downgrades For October 24, 2022
October 24, 2022
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2022/10/24/image20.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/analyst_ratings_image_5890.png?width=1200&height=800&fit=crop)
Benzinga's Top Ratings Upgrades, Downgrades For October 19, 2022
October 19, 2022
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2022/10/19/image28.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/10/19/image23.jpeg?width=1200&height=800&fit=crop)
![](https://mms.businesswire.com/media/20221018006327/en/1115287/4/Latest_KSF_M%26A.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/10/18/image41_0.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/10/18/image34.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/10/18/image21_0.jpeg?width=1200&height=800&fit=crop)
![](https://investorplace.com/wp-content/uploads/2022/08/student-loan-college-1600-1024x576.png)
![](https://cdn.benzinga.com/files/images/story/2022/movers_image_19382.jpeg?width=1200&height=800&fit=crop)
![](https://investorplace.com/wp-content/uploads/2022/09/rmed1600.png)
![](https://cdn.benzinga.com/files/images/story/2022/10/18/image38.jpeg?width=1200&height=800&fit=crop)
![](https://investorplace.com/wp-content/uploads/2021/08/srne_doctor_oncology_1600.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/10/18/exxon_2012-03-13_exxon_with_shop__go_in_durham.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/movers_image_19357.jpeg?width=1200&height=800&fit=crop)
![](https://mms.businesswire.com/media/20221018005796/en/1567526/5/Firm_Logo-with_Investor_Law_Firm.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/10/18/image21.jpg?width=1200&height=800&fit=crop)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Business Insurance is a singular, authoritative news and information source for executives focused upon risk management, risk transfer and risk financing.
Never miss important news. Subscribe to our newsletter.
Register for free